United Kingdom
# |
Name |
Capital Expenditure |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD -3.78 B
|
Dec. 31, 2023 | USD 140.24 | -0.22% |
|
United Kingdom |
|
2 |
USD -2.98 B
|
Dec. 31, 2023 | USD 17.39 | -0.08% |
|
United Kingdom |
|
3 |
USD -427.50 M
|
Dec. 31, 2023 | USD 4.67 | 0.65% |
|
United Kingdom |
|
4 |
USD -427.00 M
|
Dec. 31, 2023 | USD 12.79 | 0.04% |
|
United Kingdom |
|
5 |
USD -169.00 M
|
Dec. 31, 2023 | USD 28.38 | -0.06% |
|
United Kingdom |
|
6 |
USD -129.20 M
|
Dec. 31, 2023 | USD 3.02 | -1.33% |
|
United Kingdom |
|
7 |
USD -110.55 M
|
July 31, 2024 | USD 25.30 | -1.17% |
|
United Kingdom |
|
8 |
USD -107.38 M
|
Dec. 31, 2023 | USD 2.89 | -0.48% |
|
United Kingdom |
|
9 |
USD -65.11 M
|
March 31, 2024 | USD 37.51 | -0.51% |
|
United Kingdom |
|
10 |
USD -34.98 M
|
Dec. 31, 2023 | USD 49.95 | -1.36% |
|
United Kingdom |
|
11 |
USD -26.35 M
|
Sept. 30, 2024 | USD 56.22 | -0.33% |
|
United Kingdom |
|
12 |
USD -12.51 M
|
Dec. 31, 2023 | USD 5.04 | -2.51% |
|
United Kingdom |
|
13 |
USD -11.46 M
|
Dec. 31, 2023 | USD 1.98 | 0.38% |
|
United Kingdom |
|
14 |
USD -10.99 M
|
Dec. 31, 2023 | USD 2.21 | 0.46% |
|
United Kingdom |
|
15 |
USD -8.87 M
|
Dec. 31, 2023 | USD 0.32 | 2.99% |
|
United Kingdom |
|
16 |
USD -7.47 M
|
Dec. 31, 2023 | USD 1.42 | -3.02% |
|
United Kingdom |
|
17 |
USD -6.59 M
|
Dec. 31, 2023 | USD 0.24 | -0.40% |
|
United Kingdom |
|
18 |
USD -5.83 M
|
March 31, 2024 | USD 0.80 | 0.38% |
|
United Kingdom |
|
19 |
USD -5.42 M
|
Dec. 31, 2023 | USD 32.88 | 0.83% |
|
United Kingdom |
|
20 |
USD -4.30 M
|
June 30, 2024 | USD 0.07 | -16.83% |
|
United Kingdom |
|
21 |
USD -3.75 M
|
Dec. 31, 2023 | USD 0.03 | -3.20% |
|
United Kingdom |
|
22 |
USD -2.93 M
|
Dec. 31, 2023 | USD 13.39 | 4.86% |
|
United Kingdom |
|
23 |
USD -2.73 M
|
Dec. 31, 2023 | USD 0.16 | 0.38% |
|
United Kingdom |
|
24 |
USD -2.23 M
|
April 30, 2024 | USD 0.65 | -1.49% |
|
United Kingdom |
|
25 |
USD -2.08 M
|
March 31, 2024 | USD 0.09 | -6.74% |
|
United Kingdom |
|
26 |
USD -1.92 M
|
Dec. 31, 2023 | USD 0.20 | -2.58% |
|
United Kingdom |
|
27 |
USD -1.90 M
|
Dec. 31, 2023 | USD 14.61 | -1.71% |
|
United Kingdom |
|
28 |
USD -1.61 M
|
Dec. 31, 2023 | USD 0.59 | 0.38% |
|
United Kingdom |
|
29 |
USD -1.53 M
|
Dec. 31, 2023 | USD 0.23 | 1.77% |
|
United Kingdom |
|
30 |
USD -1.38 M
|
March 31, 2024 | USD 11.13 | -2.11% |
|
United Kingdom |
|
31 |
USD -1.16 M
|
March 31, 2024 | USD 1.69 | 0.00% |
|
United Kingdom |
|
32 |
USD -885.54 K
|
Dec. 31, 2023 | USD 0.76 | 0.22% |
|
United Kingdom |
|
33 |
USD -777.39 K
|
Dec. 31, 2023 | USD 0.20 | -0.86% |
|
United Kingdom |
|
34 |
USD -629.90 K
|
Sept. 30, 2024 | USD 0.16 | 4.56% |
|
United Kingdom |
|
35 |
USD -433.86 K
|
Dec. 31, 2023 | USD 0.21 | 3.52% |
|
United Kingdom |
|
36 |
USD -419.00 K
|
Dec. 31, 2023 | USD 3.01 | 2.73% |
|
United Kingdom |
|
37 |
USD -250.82 K
|
June 30, 2024 | USD 0.22 | 1.80% |
|
United Kingdom |
|
38 |
USD -231.00 K
|
Dec. 31, 2023 | USD 0.05 | 0.38% |
|
United Kingdom |
|
39 |
USD -221.10 K
|
April 30, 2024 | USD 0.12 | -0.69% |
|
United Kingdom |
|
40 |
USD -192.12 K
|
Dec. 31, 2023 | USD 0.70 | -3.05% |
|
United Kingdom |
|
41 |
USD -169.00 K
|
Dec. 31, 2023 | USD 16.92 | 0.06% |
|
United Kingdom |
|
42 |
USD -149.23 K
|
Dec. 31, 2023 | USD 4.20 | -6.92% |
|
United Kingdom |
|
43 |
USD -68.76 K
|
Dec. 31, 2023 | USD 0.04 | -11.51% |
|
United Kingdom |
|
44 |
USD -66.00 K
|
Dec. 31, 2023 | USD 4.31 | 3.36% |
|
United Kingdom |
|
45 |
USD -57.25 K
|
Dec. 31, 2023 | USD 5.33 | 1.52% |
|
United Kingdom |
|
46 |
USD -48.35 K
|
Dec. 31, 2023 | USD 0.05 | 1.59% |
|
United Kingdom |
|
47 |
USD -41.99 K
|
Dec. 31, 2023 | USD 0.57 | 0.38% |
|
United Kingdom |
|
48 |
USD -39.28 K
|
Aug. 31, 2023 | USD 0.13 | 4.36% |
|
United Kingdom |
|
49 |
USD -36.71 K
|
June 30, 2024 | USD 0.03 | 1.77% |
|
United Kingdom |
|
50 |
USD -21.91 K
|
June 30, 2024 | USD 0.01 | -9.39% |
|
United Kingdom |
The Healthcare company in United Kingdom with the highest Capital Expenditure is AstraZeneca PLC (LSE: AZN.L) at USD -3.78 B.
The Healthcare company in United Kingdom with the lowest Capital Expenditure is Sareum Holdings plc (LSE: SAR.L) at USD 0.00.
The top 10 Healthcare companies in United Kingdom by Capital Expenditure are AstraZeneca PLC, GSK plc, Haleon plc, Smith & Nephew plc, Hikma Pharmaceuticals PLC, ConvaTec Group Plc, Smiths Group plc, Spire Healthcare Group plc, Halma plc and LivaNova PLC.
The bottom 10 Healthcare companies in United Kingdom by Capital Expenditure are Sareum Holdings plc, Akari Therapeutics, Plc, OKYO Pharma Limited, Fusion Antibodies plc, Aptorum Group Limited, Genflow Biosciences plc, Feedback plc, Synairgen plc, Bioventix PLC and Physiomics Plc.